Kyntra Bio (KYNB) Prepaid Assets (2014 - 2026)
Kyntra Bio (KYNB) posted Prepaid Assets of $556000.0 for Q1 2026, down 90.94% sequentially from $6.1 million in Q4 2025, and down 83.28% YoY from $3.3 million in Q1 2025.
Kyntra Bio (KYNB) Prepaid Assets (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Prepaid Assets for 13 years, with the latest figure at $556000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 83.28% year-over-year to $556000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $556000.0 (down 83.28% YoY) and the FY2025 annual result came in at $6.1 million, down 80.55% from the prior year.
- Prepaid Assets eased to $556000.0 in Q1 2026 per KYNB's latest filing, from $6.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $60.6 million in Q3 2024 and troughed at $556000.0 in Q1 2026.
- A 5-year average of $14.5 million and a median of $8.0 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 549.68% in 2024, then sank 98.85% in 2025.
- Over 5 years, Prepaid Assets stood at $4.4 million in 2022, then grew by 11.53% to $4.9 million in 2023, then jumped by 549.68% to $31.5 million in 2024, then plunged by 80.55% to $6.1 million in 2025, then plunged by 90.94% to $556000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $556000.0, $6.1 million, and $695000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.78 Mn |
| Mar 31, 2026 | 556,000.00 |
| Dec 31, 2025 | 6.14 Mn |
| Sep 30, 2025 | 695,000.00 |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 31.54 Mn |
| Sep 30, 2024 | 60.56 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 36.15 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 40.38 Mn |
| Jun 30, 2023 | 8.86 Mn |
| Mar 31, 2023 | 14.49 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 8.04 Mn |
| Mar 31, 2022 | 9.39 Mn |
| Dec 31, 2021 | 5.07 Mn |
| Sep 30, 2021 | 6.60 Mn |